Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
35 GBX | -2.78% | -10.26% | +52.17% |
May. 08 | EARNINGS: International Biotechnology bullish; Andrews Sykes profit up | AN |
Mar. 20 | Cornerstone FS plans to change name to Finseta as part of growth plan | AN |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Capitalization 1 | 6.996 | 3.256 | 23.35 | 23.35 | - |
Enterprise Value (EV) 2 | 6.996 | 3.256 | 15.22 | 21.72 | 18.47 |
P/E ratio | - | - | 6.12 x | 19.4 x | 9.72 x |
Yield | - | - | - | - | - |
Capitalization / Revenue | 2.63 x | 0.59 x | 1.36 x | 1.75 x | 1.42 x |
EV / Revenue | 2.63 x | 0.59 x | 1.36 x | 1.62 x | 1.13 x |
EV / EBITDA | -4.71 x | -3.25 x | 7.7 x | 9.83 x | 4.96 x |
EV / FCF | -6 x | -2.17 x | 33.4 x | 23.4 x | 6.36 x |
FCF Yield | -16.7% | -46.1% | 3% | 4.28% | 15.7% |
Price to Book | - | - | - | - | - |
Nbr of stocks (in thousands) | 20,278 | 48,036 | 57,417 | 57,417 | - |
Reference price 3 | 0.2900 | 0.0600 | 0.3500 | 0.3500 | 0.3500 |
Announcement Date | 6/30/22 | 5/16/23 | 5/8/24 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Net sales 1 | 1.933 | 2.664 | 5.551 | 11.22 | 13.38 | 16.41 |
EBITDA 1 | - | -1.485 | -1.001 | 1.976 | 2.211 | 3.723 |
EBIT 1 | - | -1.661 | -1.463 | 1.253 | 1.629 | 3.025 |
Operating Margin | - | -62.35% | -26.35% | 11.17% | 12.17% | 18.44% |
Earnings before Tax (EBT) 1 | - | - | -6.662 | 1.5 | 1.279 | 2.441 |
Net income 1 | - | - | -6.461 | 2.481 | 1.279 | 2.441 |
Net margin | - | - | -116.38% | 22.11% | 9.56% | 14.88% |
EPS 2 | - | - | - | 0.0376 | 0.0180 | 0.0360 |
Free Cash Flow 1 | - | -1.167 | -1.502 | 0.696 | 0.93 | 2.906 |
FCF margin | - | -43.79% | -27.06% | 6.18% | 6.95% | 17.71% |
FCF Conversion (EBITDA) | - | - | - | 42.41% | 42.06% | 78.06% |
FCF Conversion (Net income) | - | - | - | 118.77% | 72.71% | 119.05% |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 6/8/21 | 6/30/22 | 5/16/23 | 5/8/24 | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | - | - | - | 0.12 | 1.63 | 4.88 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | - | -1.17 | -1.5 | 0.7 | 0.93 | 2.91 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - |
Capex 1 | - | 0.02 | 0.51 | 0.47 | 1.16 | 0.7 |
Capex / Sales | - | 0.76% | 9.11% | 4.13% | 8.7% | 4.25% |
Announcement Date | 6/8/21 | 6/30/22 | 5/16/23 | 5/8/24 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+52.17% | 25.15M | |
+10.66% | 321B | |
+26.23% | 220B | |
+3.30% | 150B | |
+13.73% | 57.95B | |
+14.14% | 32.83B | |
+3.00% | 30.44B | |
+86.90% | 20.94B | |
+28.33% | 21.13B | |
+2.17% | 14.97B |
- Stock Market
- Equities
- CSFS Stock
- Financials Cornerstone FS plc